Skip to content
  • My Profile
  • Register
  • Log In
  • Watchlist
AlphaStreet

News . Data . Research

MENUMENU
  • News
          • Technology
          • Consumer
          • Health Care
          • Industrials
          • Cannabis
          • Retail
          • Finance
          • Energy
          • IPO
          • Leisure & Entertainment
          • Research Summary
          • Other Industries
  • News
    • Cannabis
    • Consumer
    • Energy
    • Finance
    • Health Care
    • Industrials
    • IPO
    • Leisure & Entertainment
    • Other Industries
    • Research Summary
    • Retail
    • Technology
  • AlphaGraphs
  • Earnings Transcripts
  • Earnings Calendar
  • IR Services
  • Log In
  • Register
  • My Profile
  • Watchlist

Categories Earnings, Health Care

Merck strengthens animal health division with $2.4-bln Antelliq buyout

December 14, 2018April 20, 2020

Taking a cue from the growing demand for animal care products, healthcare service providers and pharma companies are enhancing their offerings in that segment. The annual sales of medicines and medical devices for pets and livestock increased exponentially in the last few years, and the trend is expected to continue.

In one of the biggest deals the sector has witnessed in recent times, in terms of value, pharmaceutical giant Merck & Co. (MRK) has decided to invest $2.4 billion for acquiring the assets of Antelliq Group, a privately held manufacturer of identification products for companion animals and livestock.

By owning the unique product portfolio of Antelliq, which is specialized in digital systems that process information about animals and keep their owners updated, Merck expects to expand the market share of its animal health unit. The products are designed to help optimize disease prediction and treatment. The new business will enhance overall growth while creating additional value for Merck’s shareholders.

By acquiring Antelliq, which is specialized in digital systems that process information about animals, Merck expects to expand the market share of its animal health unit

However, the market seems to be skeptical about the prospects of the new venture. Merck’s shares lost about 2% in the premarket Friday and continued to fall in the early trading hours in a selloff that followed the announcement. The stock had hit a 10-year high earlier this month, after gaining 38% over the past twelve months.

“Antelliq’s people and products complement this portfolio by adding market-leading digital products, extending the range of solutions we can provide our customers and further driving the growth of our business,” said Merck CEO Kenneth Frazier.

Merck Q3 profit beats estimates

After integration, Antelliq will operate as a standalone entity and as a wholly owned subsidiary under Merck Animal Health. The transaction, which is expected to close in the second quarter of 2019, includes the assumption of 1.2 billion euros in Antelliq’s debt. It is estimated that repayment of the debt will impact Merck’s second-quarter results.

The company’s animal health division generated sales of $1.02 billion in the third quarter, up 2% from last year. Total earnings increased 7.2% to $1.19 per share during the period, aided by higher revenues and the management’s aggressive efforts to reduce cost.

 

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

Most Popular

HOG Earnings: Key quarterly highlights from Harley-Davidson’s Q4 2022 financial results

Harley-Davidson, Inc. (NYSE: HOG) reported fourth quarter 2022 earnings results today. Revenue increased 12% year-over-year to $1.14 billion. Net income attributable to Harley-Davidson, Inc. rose 94% YoY to $42 million,

After positive Q4, Advanced Micro Devices (AMD) looks at a mixed 2023

Advanced Micro Devices, Inc. (NASDAQ: AMD) this week issued a cautious outlook for the first quarter of 2023, after reporting stronger-than-expected fourth-quarter results. The chipmaker did not provide full-year guidance,

META Earnings: All you need to know about Meta Platforms’ Q4 2022 earnings results

Meta Platforms, Inc. (NASDAQ: META) reported fourth quarter 2022 earnings results today. Revenue declined 4% year-over-year to $32.17 billion. Net income fell 55% to $4.6 billion while EPS dropped 52%

Tags

Business News

Related Articles

  • Merck (MRK) Earnings: 4Q22 Key Numbers

  • Merck & Co Inc (MRK) Q3 2022 Earnings Call Transcript

  • Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings

  • Is Merck & Co. (MRK) a good investment after Q1 earnings?

  • Infographic: Highlights of Merck’s (MRK) Q1 2022 earnings

© 2020 AlphaStreet Inc. All Rights Reserved

Quick Links

  • AlphaGraphs
  • Earnings Transcripts
  • Earnings Calls
  • Contact
  • Company
  • The Team

Contact Info

info@alphastreet.com

44053 Fremont Blvd,
Fremont, CA 94538

Add Comment
Loading...

Cancel reply

Cancel
Viewing Highlight
Loading...
Highlight
Close
Top